Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia

BSE1110.054.15 (+0.38 %)

PREV CLOSE ( ) 1105.90

OPEN PRICE ( ) 1097.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5198

TODAY'S LOW / HIGH ( )1088.35 1113.95

52 WK LOW / HIGH ( )823.7 1309

NSE1109.603.6 (+0.33 %)

PREV CLOSE( ) 1106.00

OPEN PRICE ( ) 1099.30

BID PRICE (QTY) 1109.60 (126)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 126775

TODAY'S LOW / HIGH( ) 1086.50 1114.80

52 WK LOW / HIGH ( )802 1309.9

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

9806.00

1705.00

278.00

6304.47

12120.10

Adjustment

2181.00

7554.00

7829.00

5794.74

7164.75

Changes In working Capital

1118.00

2531.00

543.00

-1782.87

2499.00

Cash Flow after changes in Working Capital

13105.00

11790.00

8650.00

10316.34

21783.85

Cash Flow from Operating Activities

10721.00

9713.00

6607.00

8375.43

17842.65

Cash Flow from Investing Activities

4877.00

-6079.00

-5444.00

-3803.70

-7390.14

Cash Flow from Financing Activities

-14527.00

-4325.00

-1567.00

-325.99

-17093.86

Net Cash Inflow / Outflow

1071.00

-691.00

-404.00

4245.74

-6641.35

Opening Cash & Cash Equivalents

9564.00

10139.00

9838.00

5019.57

12308.14

Cash & Cash Equivalent on Amalgamation / Take over / Merger

-769.81

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

248.00

116.00

705.00

572.88

122.59

Closing Cash & Cash Equivalent

10883.00

9564.00

10139.00

9838.19

5019.57